Oramed Submits Pre-IND Package to FDA for ORMD-0901 (oral exenatide), an …
MarketWatch
JERUSALEM, September 3, 2013 /PRNewswire via COMTEX/ — Oramed Pharmaceuticals Inc. (nasdaqcm:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has submitted a pre-Investigational New Drug … capsule …
